Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Third Harmonic Bio, Inc. (THRD) since 2022 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Third Harmonic Bio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1923840.
Total stock buying since 2022: $56,979,584.
Total stock sales since 2022: $15,659,781.
Total stock option exercises since 2022: $344,900.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 1,089,087 | $15,479,231 | 64,467 | $270,758 |
| 2023 | 0 | $0 | 17,653 | $180,550 | 17,653 | $74,142 |
| 2022 | 3,514,063 | $56,979,584 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-11 | 0 | $0 | 2,117 | $31,755 | 2,117 | $8,891 |
| 2024-10 | 0 | $0 | 1,002,673 | $14,340,095 | 2,673 | $11,226 |
| 2024-09 | 0 | $0 | 14,790 | $214,575 | 14,790 | $62,117 |
| 2024-06 | 0 | $0 | 10,000 | $124,570 | 10,000 | $42,000 |
| 2024-05 | 0 | $0 | 44,842 | $591,949 | 20,222 | $84,932 |
| 2024-04 | 0 | $0 | 14,665 | $176,287 | 14,665 | $61,592 |
| 2023-12 | 0 | $0 | 17,653 | $180,550 | 17,653 | $74,142 |
| 2022-12 | 214,063 | $879,584 | 0 | $0 | 0 | $0 |
| 2022-09 | 3,300,000 | $56,100,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-08 | Conner Edward R. (Chief Medical Officer) | Sale | 2,117 | 15.00 | 31,755 |
| 2024-11-08 | Conner Edward R. (Chief Medical Officer) | Option Ex | 2,117 | 4.20 | 8,891 |
| 2024-10-29 | Lampert Mark N | Sale | 1,000,000 | 14.30 | 14,300,000 |
| 2024-10-28 | Conner Edward R. (Chief Medical Officer) | Sale | 2,673 | 15.00 | 40,095 |
| 2024-10-28 | Conner Edward R. (Chief Medical Officer) | Option Ex | 2,673 | 4.20 | 11,226 |
| 2024-09-19 | Person Julie (CHIEF ADMINISTRATIVE OFFICER) | Sale | 9,497 | 14.29 | 135,683 |
| 2024-09-19 | Person Julie (CHIEF ADMINISTRATIVE OFFICER) | Option Ex | 9,497 | 4.20 | 39,887 |
| 2024-09-19 | Conner Edward R. (Chief Medical Officer) | Sale | 4,790 | 15.00 | 71,850 |
| 2024-09-19 | Conner Edward R. (Chief Medical Officer) | Option Ex | 4,790 | 4.20 | 20,118 |
| 2024-09-18 | Person Julie (CHIEF ADMINISTRATIVE OFFICER) | Sale | 503 | 14.00 | 7,042 |
| 2024-09-18 | Person Julie (CHIEF ADMINISTRATIVE OFFICER) | Option Ex | 503 | 4.20 | 2,112 |
| 2024-06-26 | Person Julie (CHIEF ADMINISTRATIVE OFFICER) | Sale | 10,000 | 12.46 | 124,570 |
| 2024-06-26 | Person Julie (CHIEF ADMINISTRATIVE OFFICER) | Option Ex | 10,000 | 4.20 | 42,000 |
| 2024-05-20 | Dittman Jennifer (Chief Development Oper Officer) | Sale | 1,042 | 14.00 | 14,588 |
| 2024-05-16 | Dittman Jennifer (Chief Development Oper Officer) | Sale | 23,578 | 14.04 | 331,058 |
| 2024-05-09 | Holles Natalie C. (CEO) | Sale | 20,222 | 12.18 | 246,303 |
| 2024-05-09 | Holles Natalie C. (CEO) | Option Ex | 20,222 | 4.20 | 84,932 |
| 2024-04-11 | Holles Natalie C. (CEO) | Sale | 13,558 | 12.19 | 165,217 |
| 2024-04-11 | Holles Natalie C. (CEO) | Option Ex | 13,558 | 4.20 | 56,943 |
| 2024-04-04 | Person Julie (CHIEF ADMINISTRATIVE OFFICER) | Sale | 1,107 | 10.00 | 11,070 |
| 2024-04-04 | Person Julie (CHIEF ADMINISTRATIVE OFFICER) | Option Ex | 1,107 | 4.20 | 4,649 |
| 2023-12-05 | Person Julie (Chief Administrative Officer) | Sale | 12,863 | 10.30 | 132,488 |
| 2023-12-05 | Person Julie (Chief Administrative Officer) | Option Ex | 12,863 | 4.20 | 54,024 |
| 2023-12-05 | Conner Edward R. (Chief Medical Officer) | Sale | 4,790 | 10.03 | 48,062 |
| 2023-12-05 | Conner Edward R. (Chief Medical Officer) | Option Ex | 4,790 | 4.20 | 20,118 |
| 2022-12-20 | Lampert Mark N | Buy | 214,063 | 4.11 | 879,584 |
| 2022-09-19 | Atlas Venture Associates Opportunity I, Llc (10% Owner) | Buy | 1,500,000 | 17.00 | 25,500,000 |
| 2022-09-19 | Orbimed Capital Gp Vii Llc (Director) | Buy | 300,000 | 17.00 | 5,100,000 |
| 2022-09-19 | Bonita David P (Director) | Buy | 300,000 | 17.00 | 5,100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of THRD listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Third Harmonic Bio, Inc. (symbol THRD, CIK number 1923840) see the Securities and Exchange Commission (SEC) website.